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Abstract
The presence of abnormalities of the respiratory center in obstructive
sleep apnea (OSA) patients and their correlation with polysomnographic
data are still a matter of controversy. Moderately obese, sleep-de-
prived OSA patients presenting daytime hypersomnolence, with
normocapnia and no clinical or spirometric evidence of pulmonary
disease, were selected. We assessed the ventilatory control and corre-
lated it with polysomnographic data. Ventilatory neuromuscular drive
was evaluated in these patients by measuring the ventilatory response
(VE), the inspiratory occlusion pressure (P
.1) and the ventilatory
pattern (VT/TI, TI/TTOT) at rest and during submaximal exercise,
breathing room air. These analyses were also performed after inhala-
tion of a hypercapnic mixture of CO2 (∆P.1/∆PETCO2,  ∆VE/∆PETCO2).
Average rest and exercise ventilatory response (VE: 12.2 and 32.6 l/
min, respectively), inspiratory occlusion pressure (P
.1: 1.5 and 4.7
cmH2O, respectively), and ventilatory pattern (VT/TI: 0.42 and 1.09 l/
s; TI/TTOT: 0.47 and 0.46 l/s, respectively) were within the normal
range. In response to hypercapnia, the values of ventilatory response
(∆VE/∆PETCO2: 1.51 l min-1 mmHg-1) and inspiratory occlusion pres-
sure (∆P
.1/∆PETCO2: 0.22 cmH2O) were normal or slightly reduced in
the normocapnic OSA patients. No association or correlation between
ventilatory neuromuscular drive and ventilatory pattern, hypersomno-
lence score and polysomnographic data was found; however a signifi-
cant positive correlation was observed between P
.1 and weight. Our
results indicate the existence of a group of normocapnic OSA patients
who have a normal awake neuromuscular ventilatory drive at rest or
during exercise that is partially influenced by obesity.
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Introduction
Several studies have shown a reduction
of ventilatory drive in patients with obesity-
hypoventilation syndrome (1-4). However,
it is not yet clear whether this abnormality is
primary or secondary in its origin.
In contrast, alterations of the respiratory
center in obstructive sleep apnea (OSA) are
still controversial. Some investigators be-
lieve that obesity could stimulate the ventila-
tory drive. This hypothesis was raised by
Sampson and Grassino (5) for obese patients
without OSA with a normal ventilatory pat-
tern, but with increased inspiratory occlu-
sion pressure. The same has not been ob-
served by others (6), who showed normal
hypercapnic ventilatory response in these
subjects. Studies of obese OSA patients have
indicated a reduced hypercapnic ventilatory
response compared to obese subjects with-
out OSA (7) or when an inspiratory load was
imposed (8).
The role of upper airway obstruction in
decreasing the ventilatory drive of OSA pa-
tients has been suggested in studies in which
tracheostomy (9) or continuous positive air-
way pressure (CPAP) (10) improved the hy-
percapnic response. Also, sleep deprivation
as the cause of reduction in the hypercapnic
ventilatory response has been shown to oc-
cur in normal subjects (11-13). The disparity
of data reported in these studies is probably
due to the use of different methods and a
heterogeneous patient series.
In the present study we evaluated OSA
patients presenting the following character-
istics: a) moderate obesity (14); b) sleep
deprivation and fragmentation reflected by
reduced sleep efficiency and altered sleep
architecture, with resulting daytime hyper-
somnolence assessed by a hypersomnolence
score (15), and c) normocapnia with no spiro-
metric alterations which might indicate ob-
structive or restrictive ventilatory distur-
bances.
The major objective of the present study
was to evalute the possible abnormalities of
the respiratory center by assessing ventila-
tory response, inspiratory occlusion pres-
sure (P
.1) and ventilatory pattern at rest
(breathing either room air or a hypercapnic
mixture) and during a metabolic increase
induced by exercise. We also attempted to
correlate possible alterations of these vari-
ables with polysomnographic findings.
Patients and Methods
Subjects
Twenty-two patients with a diagnosis of
OSA who presented an apnea/hypopnea in-
dex (AHI: number of apneas and hypopneas/
total sleep time) above 15 were included in
the study. These patients were referred from
the Sleep Disorders Section of the Respira-
tory Division, Universidade Federal de São
Paulo, and were compared with normal sub-
jects studied by Moura et al. (16) to deter-
mine normal values for the variables P
.1 and
ventilatory pattern at rest and during sub-
maximal exercise, following the same proto-
col. The hypercapnic ventilatory response
was compared to the normal range reported
by Burki (17).
Exclusion criteria were 1) degree III of
obesity: body mass index (BMI) above 40
kg/m2 (14); 2) clinical diagnosis of chronic
obstructive pulmonary disease, asthma, bron-
chiectasis, obstructive or restrictive ventila-
tory insufficiency (18) assessed by simple
spirometry; 3) hypercapnia, i.e., partial
arterial carbon dioxide blood pressure
(PaCO2) above 45 mmHg determined by
arterial gasometry; 4) diseases that may
lead to secondary OSA, such as hypothy-
roidism, acromegaly, Cushing syndrome, and
other disturbances that may hinder the
patient’s ability to perform the exercise, such
as peripheral vascular insufficiency, bone
and/or joint and muscle alterations, cardiac
insufficiency and acute coronary insuffi-
ciency.
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Protocol
Clinical evaluation. A modified ques-
tionnaire (15) containing questions about
sleep, snoring, nocturnal apneas and day-
time hypersomnolence was used. Answers
were scored as 0 = never, 1 = rarely, 2 =
occasionally, and 3 = frequently. The sever-
ity of hypersomnolence was classified as
follows: 0.5 to 1 = mild, up to 2 = moderate,
and greater than 2 to 3 = severe.
Otorhinolaryngologic evaluation con-
sisted of nasofibroscopy using an FLT-S
Machida (Tokyo, Japan) apparatus connected
to a monitor, a NISCO G10 CCD-25 control
camera and a Machida RH 150 TL source
(Japan). During examination, the patient was
seated at a 45o angle in dorsal inclination
during both spontaneous breathing and
Müller maneuver. Following these proce-
dures, abnormalities of nasal cavities,
oropharynx, rhinopharynx and hypopharynx
were recorded.
Polysomnographic recording. Polysom-
nography was carried out throughout the
night. The apparatus consisted of a sleep
analyzer computer (SAC, version 9.2, Ox-
ford Instruments, Inc., Tampa FL, USA).
Thirteen channels were distributed as fol-
lows: 2 for electroencephalography, 2 for
the oculogram, 1 for chin electromyography,
2 for tibial electromyography, 1 for electro-
cardiography, 1 for airflow, 2 for thoracic-
abdominal movements, 1 for pulse oxymetry
and 1 for detection of body position. The
system automatically analyzes sleep stages
using the criteria of Rechtschaffen and Kales
(19), detecting artifacts and arousals.
At the end of the recording period, a
physician trained in polysomnographic read-
ing reanalyzed the computer-generated stag-
ing following the criteria of Rechtschaffen
and Kales (19) and making the necessary
alterations. The normal values used for anal-
ysis of sleep variables were those proposed
by Carskadon and Dement (20), and those
for respiratory events were those of
Guilleminault (21).
The variables analyzed during polysom-
nography were sleep efficiency (ratio of to-
tal sleep time/total recording time), sleep
stages 3, 4 and REM (percentage of sleeping
time), AHI and percentage of total recording
time with oxyhemoglobin saturation below
85%.
Spirometry and flow-volume curve. The
Diagnostic System Med Graphic MGC-CPx
(St. Paul, MN, USA) set on the flow mode
was used. The difference in pressure in a
linear pneumotachograph (Hans Rudolph,
model 3800, Kansas City, MO, USA) was
calculated to measure airflow. Patients were
submitted to the test at rest, in a sitting
position and breathing room air. Predicted
values were based on the formulas reported
by Knudson et al. (22) and Cherniack and
Raber (23). A series of at least 3 measure-
ments were obtained. Curves were accepted
by the system when the criteria determined
by the American Thoracic Society (24) were
reached. We analyzed as percentage of pre-
dicted values the forced vital capacity
(%FVC), the ratio of forced expired volume
in the first second (FEV1) over FVC (FEV1/
FVC in %) and the ratio of forced expired
flow at 50% of FVC/ forced inspired flow at
50% of FVC (FEF50%/FIF50%).
Maximal voluntary ventilation. After the
determination of the flow-volume curves,
patients were submitted to at least 3 maximal
voluntary ventilation (MVV) maneuvers,
which consisted of inhalations and exhala-
tions using the highest possible tidal volume
and respiratory frequency for a period of 15
s. Predictive values were those used by
Cherniack and Raber (23).
Measurements of maximal inspiratory
(MIP) and expiratory pressures (MEP). On
the same day, following a 30-min period of
rest, patients were instructed to perform
maneuvers of maximum inspiratory and ex-
piratory pressures measured with a mano-
vacuometer (±150 cmH2O; IMEBRAS, São
Paulo, SP, Brazil) and the best of 10 maneu-
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vers was considered for analysis. The crite-
ria of acceptance were those determined by
Ringqvist (25), whereas normal range values
of MIP and MEP were based on those re-
ported by Wilson et al. (26).
Arterial blood gases and pH measure-
ments. Arterial blood was anaerobically col-
lected with the patient at rest and breathing
room air. Blood gases (PaO2 and PaCO2) and
pH were determined using an ABL 330 ap-
paratus (Radiometer, Copenhagen, Den-
mark), and normal PaO2 values were calcu-
lated using regression of these variables,
according to age, as established by Mellen-
gaard (27).
Ventilatory and metabolic evaluation at
rest and during the submaximal exercise
test. The exercise test was performed on the
same day employing an electromagnetic
cycloergometer (Collins-Pedalmate, Brain-
tree, MA, USA) and variables were moni-
tored with a cardioscope and an electrocar-
diograph (FUNBEC, São Paulo, SP, Brazil).
Pulse oximetry was determined with an
oximeter (Sensor Medics, Oxyshuttle TM,
Anahein, CA, USA). Ventilatory and meta-
bolic variables (tidal volume (VT), respira-
tory rate, minute ventilation (VE), oxygen
uptake and carbon dioxide output (VCO2))
were analyzed by the Med Graphic MGC-
CPx system set on the metabolic mode. Ven-
tilation and VCO2 were obtained breath-by-
breath by integration of flow and volume
and the CO2 signal, as previously described
(28,29). A period of 2 min at rest was fol-
lowed by exercise which began with a 0 Watt
load for 2 min followed by an increment of
25 Watts for 5 min, and a further increment
of 25 Watts (total of 50 Watts) for another 5
min. Electrocardiography, oxyhemoglobin
saturation and systemic arterial blood pres-
sure were also measured simultaneously dur-
ing each period.
Determination of ventilatory pattern and
inspiratory occlusion pressure. Analysis of
the ventilatory pattern was performed at rest
and during the different exercise loads and
the values obtained were compared to those
reported by Moura et al. (16). We analyzed
VT, VE, respiratory rate, inspiratory time
(TI)/total cycle time (TTOT) ratio and the
VT/TI ratio.
During assessment of P
.1, patients were
acoustically and visually isolated from the
environment (16). Ventilatory assessment
was performed with the patient breathing
through a mouthpiece connected to a two-
way valve (Rudolph 2700) of low resistance
and 90 ml of dead space. Inspiratory flow
rate was measured with a Fleisch pneumo-
tachograph coupled to a pressure transducer
(Valydine MP, 45.1 ± 2.0 cmH2O). The gen-
erated electric signal was recorded with a
Beckman polygraph (model R-411) as in-
spiratory flow and sent to a Thompson inte-
grator (Montreal, Canada), which generated
another electric signal that corresponded to
VT on the polygraph. After a 2-min period of
adaptation, we began the recording of tidal
volume and inspiratory flow with the poly-
graph set at a speed of 10 mm/s. P
.1 was
recorded at a speed of 100 mm/s, using an
inspiratory occlusion at the level of func-
tional residual capacity produced by a pneu-
matic valve for a period of 300 ms (16,30).
This procedure was repeated as many times
as necessary to obtain 5-10 technically ac-
ceptable P
.1 curves (with no flow or volume
alteration), with at least 4 curves of flow and
tidal volume preceding each one. Bizarre
curves were excluded from P
.1 calculation
(16,30).
P
.1 values were obtained, after discarding
the first 50 ms, by measuring the pressure
variations of the occluded airway during
inspiration during the subsequent 100 ms.
This
 
assessment was performed at rest and
during the 3rd (25 Watts) and 6th min (50
Watts). Normal ranges were those deter-
mined by Moura et al. (16) in our laboratory.
Steady-state CO2 inhalation test. The pa-
tient, sitting and wearing a nasal clip, breathed
through a mouthpiece connected to a two-
way Rudolph 2700 valve coupled to a 120-l
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Douglas balloon containing an 8% CO2 and
42% O2 mixture. The system used for P.1
measurement was connected to the airways.
The expiratory port was in contact with the
environment. P
.1 was assessed after 3 min of
inhalation of the mixture. At the end of the
5th min, expiratory air was collected for 1
min through a connection with a 120-l Tissot
gasometer (Warren E. Collins, Inc., Braintree,
MA). The displacement generated by the
volume of air obtained under BTPS condi-
tions was recorded. Simultaneously, the end
tidal CO2 expired fraction was measured
with an infrared CO2 analyzer (Sensor Med-
ics, model LBII) whose output signal was
recorded with a polygraph (Beckman, model
R 411). The end tidal CO2 partial pressure
(PETCO2) was then calculated (16). The val-
ues of ∆P
.1/∆PETCO2 and ∆VE/∆PETCO2 re-
ported by Burki (17) were used as reference
values.
This study was approved by the Ethics
Committee of Hospital São Paulo and in-
formed consent was obtained from the sub-
jects.
Statistical analysis
The ventilatory neuromuscular drive, res-
piratory impedance and ventilatory pattern
of patients and normal volunteers from our
laboratory (16) were compared by the Mann-
Whitney U-test (31).
In a second phase of the analysis, patients
were separated according to the median val-
ues of the score of hypersomnolence and
polysomnographic variables, and the venti-
latory drive and the respiratory pattern of
these two subgroups were compared by the
Mann-Whitney U-test.
The possible association between neuro-
muscular ventilatory drive (P
.1, P.1/VCO2,
∆P
.1/∆PETCO2 and ∆VE/∆PETCO2) and hy-
persomnolence score, and polysomnographic
variables (sleep efficiency, arousals, AHI
and oxyhemoglobin saturation) was deter-
mined by comparing their median values by
the chi-square test or the Fisher exact test (31).
The Spearman correlation test was used
to evaluate the correlation between ventila-
tory drive variables and weight, hypersom-
nolence score, AHI and minimum oxyhemo-
globin saturation (31).
Results
The group of patients consisted of 17
men and 5 women ranging in age from 32 to
63 years, weighing 63 to 123 kg, and ranging
in height from 151 to 178 cm, which resulted
in a BMI of 25.5 to 39.3 kg/m2. Median
values are shown in Table 1. The control
group (16) consisted of 10 men ranging in
age from 23 to 32 years, weighing 57 to 85 kg
and ranging in height from 160 to 180 cm.
The OSA patients were older and heavier
than normal subjects.
The scores obtained from the clinical
questionnaire showed that 4 patients pre-
sented mild hypersomnolence (score >0.5
and <1), 14 presented moderate hypersom-
nolence (score >1 and <2), and 4 severe
hypersomnolence (score >2). None of the
normal subjects complained of hypersom-
nolence.
Table 1 - Physical characteristics and polysomno-
graphic data of OSA patients.
BMI: Body mass index; TST: total sleep time; TRT:
total recording time; SPT: sleep period time, de-
fined as the result of TST subtracted from the
initial and final latencies; AHI: apnea/hypopnea
index; SaO2<85%: percentage of TRT with oxyhe-
moglobin saturation below 85%.
Variable Median Range
Age (years) 47 32-63
Weight (kg) 90.4 63-123.5
Height (cm) 167.7 151-178
BMI (kg/m2) 32.6 25.5-39.4
TST/TRT 71.5 46.1-93.2
Stages (%SPT) 3 and 4 3.5 0-29
REM 12.7 2-42.8
AHI 48 16.2-89.5
SaO2<85% 22 0-51
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gases showed that the patients were all nor-
mocapnic (Table 2). The normal group
showed values of FVC between 76 and 104%,
with FEV1/FVC ranging from 79 to 89%.
Comparison of neuromuscular respira-
tory drive (P
.1 and P.1/VCO2), respiratory
impedance (P
.1/VT/TI), and ventilatory pat-
tern (VT/TI and TI/TTOT) showed no dif-
ference between our patients and the normal
subjects (Table 3).
Figures 1 and 2 show that most patients
presented a ventilatory drive within the nor-
mal range when it was evaluated by the ratio
between the variation (∆) of inspiratory oc-
clusion pressure and the variation of PETCO2,
before and after the inhalation of a hypercap-
nic mixture (∆P
.1/∆PETCO2), and by the ratio
between the variation of minute ventilation
and the variation of PETCO2 (∆VE/∆PETCO2).
Two of these patients, however, presented
∆P
.1/∆PETCO2 values (0.11 and 0.10 cmH2O/
mmHg) slightly below the normal range (nor-
mal values are between 0.12 and 2.64 cmH2O/
mmHg) (17). These patients also presented
reduced ∆VE/∆PETCO2 values (0.94 and 1.09
l min-1 mmHg-1), while the normal range is
between 1.16 and 6.18 l min-1 mmHg-1 (17).
The former patient had the most reduced P
.1
value at rest (0.8 cmH2O), meaning a reduc-
tion of ventilatory drive but without evi-
dence of alveolar hypoventilation. The other
patient had the highest BMI value (39.3 kg/
m2) and reduced MIP (66 cmH2O).
In order to establish whether clinical and
polysomnographic abnormalities influence
the ventilatory drive, our patients were re-
classified based on a cut-off point that corre-
sponded to the median value of hypersom-
nolence score, sleep efficiency, number of
arousals, AHI, and the percentage of total
recording time in which saturation remained
below 85%. Comparison between subgroups
did not reveal any difference in neuromuscu-
lar drive (P
.1, P.1/VCO2), respiratory impe-
dance (P
.1/VT/TI), ventilatory pattern (VT/
TI, TI/TTOT) at rest and during exercise or
the hypercapnic test (∆P
.1/∆PETCO2 and ∆VE/
Table 2 - Pulmonary function test and arterial blood
gases in OSA patients.
%: Percent of predicted value, when % is placed
before the variable; FVC: forced vital capacity;
FEV1: forced expired volume during the first sec-
ond of FVC; FEF50%: forced expired flow at 50% of
FVC; FIF50%: forced inspired flow at 50% of FVC;
MVV: maximal voluntary ventilation; MIP: maximal
inspiratory pressure; MEP: maximal expiratory
pressure; PaO2: partial O2 pressure in arterial
blood; PaCO2: partial CO2 pressure in arterial
blood.
Variable Median Range
%FVC 105.5 76-133
FEV1/FVC(%) 81.5 68-88
FEF50%/FIF50% 0.84 0.32-2.86
%MVV 90.5 67-149
%MIP 112 73-162
%MEP 106.5 90-123
PaO2 82 56-108
PaCO2 38 30-43
Otorhinolaryngological evaluation re-
vealed that of the 22 patients 12 showed
inferior turbinate hypertrophy and 11 pre-
sented septum deviation (10 of whom showed
degrees II and III). Upon oropharynx exami-
nation, 12 patients presented uvula edema
and 7 uvula stretching, 5 patients had hyper-
trophied tonsils and 1 had an increased tongue
base. Nasofibroscopy during the Müller ma-
neuver revealed obstruction at the level of
the velopharyngeal sphincter in 18 patients.
Of these, 2 presented obstruction at the tongue
base level, 1 at the hypopharynx level, and 1
at all levels.
Polysomnographic findings revealed that
patients presented reduced sleep efficiency
and superficial sleep, with decreased stages
3, 4 and REM. AHI was above 30 in 13
patients, characterizing moderate to severe
OSA (Table 1).
Spirometry, MVV, MIP and MEP re-
vealed mostly normal results for the patients
(Table 2). Analysis of the flow-volume curve
revealed the presence of sawtooth values in
12 patients and an FEF50%/FIF50% ratio above
1 in eight patients. Analysis of arterial blood
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∆PETCO2).
Also, no correlation was found between
the neuromuscular drive and the above vari-
ables, except for a weak but significant cor-
relation between P
.1 at rest and weight (r =
0.48, P = 0.02).
Discussion
Our results point to a group of normocap-
nic obese OSA patients with ventilatory neu-
romuscular drive (P
.1, P.1/VCO2) and venti-
latory pattern (VT/TI, TI/TTOT) in the nor-
mal range at rest and during exercise. Also,
the positive correlation between P
.1 at rest
and weight may indicate a possible load
effect stimulation of obesity on the ventila-
tory drive in our patients. This hypothesis is
supported by the study of Sampson and
Grassino (5) who described similar results,
i.e., a positive correlation between obesity
and P
.1 values in obese non-OSA subjects.
However, when the neuromuscular drive was
evaluated by the hypercapnic ventilatory re-
sponse (HVR), we found normal or slightly
reduced values of ∆P
.1/∆PETCO2 and ∆VE/
∆PETCO2, which were not correlated with
subject weight. Gold et al. (7) found a re-
duced HVR in obese OSA patients as com-
pared to obese non-OSA subjects and, since
the respiratory mechanics were similar for
both groups, the authors postulated that a
primary chemoresponsiveness defect may
be responsible for the alterations found in
OSA patients.
Other authors (8) have shown that nor-
mocapnic OSA patients have preserved HVR
but a decreased response compared to nor-
mal subjects when an inspiratory load is
imposed, suggesting that these patients have
an altered ventilatory drive, since they did
not increase ventilation in response to an
inspiratory load. Furthermore, they hypoth-
esized that daytime somnolence was the cause
of such abnormality.
The hypothesis that sleep quality of OSA
patients can interfere with chemoresponsive-
ness during waking is still controversial. Sleep
deprivation can lead to altered body temper-
ature, opiate secretion, and daytime hyper-
somnolence, all of which could explain the
inhibition of the respiratory center (13). Stud-
ies that addressed this issue also report dis-
putable results. Espinoza et al. (12) did not
find changes in HVR in normal subjects
following 2 nights of sleep fragmentation. In
contrast, White et al. (13) found a 24% re-
duction of HVR and a 29% reduction of the
ventilatory response to hypoxemia in 24-h
sleep-deprived subjects. Similar results were
reported by Cooper and Phillips (11), with a
20% decrease of HVR in subjects submitted
to total sleep for 24 h. The deprivation re-
ported in the above studies and that used
here differ in two major aspects: normal
Table 3 - Ventilatory pattern, ventilatory drive and respiratory impedance in OSA
patients and normal volunteers, both at rest (Rest) and during submaximal 50-Watt
exercise (Ex).
Data are reported as median and range. VT: Tidal volume; TI: inspiratory time; TOT:
total time; P
.1: inspiratory occlusion pressure; VCO2: CO2 output; VE: minute ventila-
tion.
OSA patients Normal volunteers
(N = 22) (N = 10)
VT/TI (l/sec)
Rest 0.42 (0.21-0.80) 0.5 (0.38-0.84)
Ex 1.09 (0.77-1.47) 1.06 (0.63-1.28)
TI/TOT
Rest 0.47 (0.35-0.59) 0.39 (0.31-0.46)
Ex 0.46 (0.41-0.56) 0.46 (0.41-0.51)
Respiratory rate
Rest 15.1 (10.4-27.6) 15.2 (10.8-17.5)
Ex 24.5 (10-49) 20.3 (14.1-29.9)
VT (l)
Rest 0.73 (0.36-1.18) 0.83 (0.57-1.72)
Ex 1.45 (0.65-2.67) 1.38 (0.82-2.17)
VE (l/min)
Rest 12.2 (5.4-18.2) 12.5 (8.9-23.12)
Ex 32.6 (23.4-42.3) 29 (16.34-35.71)
P
.1 (cmH2O)
Rest 1.5 (0.8-6.2) 1.4 (0.51-2.42)
Ex 4.7 (2-14.3) 4.3 (2.39-5.60)
P
.1/VCO2 (cmH2O/ml)
Rest 6.1 (2.2-14) 4.5 (2.12-10.52)
Ex 5.1 (2.5-12) 4.7 (2.32-6)
P
.1/VT/TI (cmH2O l-1 s-1)
Rest 3.5 (1.4-16.3) 2.9 (1.24-4.48)
Ex 4.4 (2.3-15) 4.5 (2.23-6.83)
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Figure 1 - Individual values of
∆P
.1/∆PETCO2 in normocapnic
patients with OSA. The horizon-
tal line corresponds to the lower
limit of normality at 0.12 cmH2O/
mmHg (17).
∆P
.
1/∆
P E
TC
O
2
0.8
Patients
0.6
0
0.2
0.4
∆V
E/
∆P
ET
CO
2
2.5
Patients
2.0
0
1.0
1.5
0.5
Figure 2 - Individual values of
∆VE/∆PETCO2 in normocapnic
patients with OSA. The horizon-
tal line corresponds to the lower
limit of normality at 1.16 l min-1
mmHg-1 (17).
subjects were used in all of them and these
subjects were sleep deprived for 24-48 h,
which is considered an acute deprivation.
The HVR obtained for our patients (Figures
1 and 2) who presented with chronic sleep
deprivation and/or fragmentation might be
considered blunted, since higher values
would be expected, as reported by Gold
et al. (7) for obese non-OSA subjects.
However, no association or correlation was
found between this response and AHI, sleep
efficiency, arousals, or hypersomnolence
score.
Some studies report an improvement of
HVR following treatment of upper airway
obstruction by tracheostomy (9) or with the
use of nasal CPAP (10) in OSA patients.
These results suggest a direct or secondary
effect of obstructive sleep apnea reducing
the hypercapnic ventilatory drive. Studies
utilizing nasal CPAP in OSA patients are
currently in progress in our service to test the
above hypothesis.
Our results indicate the existence of a
group of obese, normocapnic OSA patients
who have a normal awake ventilatory drive
at rest and during exercise which is partially
influenced by obesity.
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